Research and Development Expenses of Abbott Laboratories
Abbott Laboratories Research and Development Expenses 2012-2021
Amounts are in $millions.
| Year | Research & Development expenses ($mn) |
| 2021 | $2,742 |
| 2020 | $2,420 |
| 2019 | $2,440 |
| 2018 | $2,300 |
| 2017 | $2,260 |
| 2016 | $1,447 |
| 2015 | $1,408 |
| 2014 | $1,349 |
| 2013 | $1,371 |
| 2012 | $1,461 |
Abbott Laboratories spent $2,742 million on research and development in 2021 compared to $$2,420 million in 2020.
The research and development expenses of Abbott Laboratories in 2020 remained $2.42 billion compared to $2.44 billion in 2019.
Research and Development Expenses of Abbott Laboratories were $2,300 million in 2018 compared to $2,260 million in 2017.
About Abbott:
Abbott Laboratories is an Illinois corporation, incorporated in 1900. Its main business is the discovery, development, manufacture, and sale of a broad and diversified line of health care products.
Abbott has four reportable segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Cardiovascular and Neuromodulation Products.